Convatec Welcomes Postponement of Local Coverage Determinations on Skin Substitutes Until January 2026
SHERIDAN, WYOMING – May 7, 2025 – Convatec, a leading provider of medical products and technologies, has expressed its support for the postponement of Local Coverage Determinations (LCDs) for skin substitutes in the United States until January 2026. This delay, made by the Centers for Medicare & Medicaid Services (CMS), ensures that Medicare patients in the US will continue to have access to InnovaMatrix®, a trusted product for treating diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).